How Foreigners Choose International Insurance for China

If you're coming to China for under 30 days for a single procedure, the product comparison table below plus the "five common traps" at the end will get you there. If you're planning a 30–180 day stay with multiple follow-ups or several treatments in parallel, this guide is for you. If you intend to live in China for a year or more and you're looking for a family policy outside of any employer-provided cover, picking a long-term annual international medical insurance (IPMI) plan is more complex than this guide tackles — contact a licensed broker such as Pacific Prime, William Russell, or Alea.

This guide does not recommend any specific insurance product. We lay out the facts, the differences, and the items you should verify when making your choice. The final product decision belongs to you (or a licensed broker).

Three questions decide everything

International insurance shopping looks complicated but 80% of the decision comes down to three questions: how long you'll be in China, what treatment you're planning, and what's on your health declaration. The combinations of these three answers make one of three product types (travel medical, short-term IPMI, annual IPMI) clearly suitable and the other two clearly not.

The tool below walks you through the three questions in about 60 seconds. It outputs a product type recommendation, one or two alternatives, and a handful of specific warnings and tips. It is not a quote — premiums come from a broker — but it shrinks your search range from "10 insurers × 4 tiers × 5 riders" to "2–3 insurers × 1–2 tiers" before you take that range to a broker for actual pricing.

[ The <InsuranceFinder /> tool is embedded here. ]

When each product type fits

Travel medical insurance is for people whose trip is mainly about something else and medical risk is a side concern. It covers an unexpected appendix attack, a fall, a cardiac scare after arrival. It does not cover "the full-arch implant I came for" or "the IVF cycle I have scheduled." If the trip's purpose is a specific procedure, travel medical will almost certainly reject the claim — that's pre-known intent, classified as elective treatment outside scope.

Short-term IPMI is for people staying in China for the medium term who want active medical access and accept tier limits. Now Health's SimpleCare, Cigna's short-term products, AXA's short-stay plans sit here. They cover inpatient plus some outpatient plus some elective procedures, but tier choice is narrow and monthly premium runs 10–20% higher than annual equivalents.

Annual IPMI is for people planning a year-plus stay who want inpatient + outpatient + dental + maternity (optional) full coverage plus dense direct billing at Chinese international hospitals. Cigna Global, Bupa Global, AXA Global Healthcare, Allianz Care, Now Health all target this. The cost is a 12-month commitment plus one-shot underwriting plus waiting periods (pre-existing typically 2 years, maternity typically 12 months).

Six dimensions that decide which insurer wins for you

Every insurer's marketing copy ("comprehensive global cover," "extensive China network," "award-winning service") sounds the same. What actually determines your experience are these six things. Get clear answers on these six from each candidate insurer and you'll narrow 10 to 2–3.

China network density. How many hospitals the insurer has signed with in China, and whether they're the ones you want to go to. Most insurers claim "60+ China network hospitals" but specific lists are only handed to you after the policy goes live. At quote stage you can only ask the broker to estimate or use the insurer's hospital locator (incomplete). This dimension directly determines whether you can use direct billing: in-network = direct billing, no cash; out-of-network = reimbursement (pay upfront + claim 4–12 weeks later from home country).

Pre-existing condition handling. Industry standard is a 2-year waiting period for pre-existing conditions, meaning the first 2 years of the policy do not cover anything tied to that condition. Rules vary: some insurers require the condition to be "stable for 6–12 months" before considering coverage; some allow underwriting waivers (with a surcharge); some standard-cover certain conditions outright (stable hypertension, controlled asthma). This dimension decides whether you can buy, and when the policy actually starts covering what you need.

Claims turnaround. Real days from submitting documentation to insurer payout. AXA Global Healthcare publishes 80%+ of claims paid within 48 hours (with complete docs). Cigna and Bupa don't publish the same metric; broker observations put them in the 5–21 day range. This dimension means the difference between waiting 30 days versus 12 weeks while floating your own money.

Direct billing scope (beyond China). If your itinerary is HKG/SGN transit plus Shanghai surgery plus Hong Kong follow-up, you need direct-billing partners in three cities. Cigna and Bupa have dense global networks; AXA and Allianz are stable in major Southeast Asian cities; Now Health is sharper in APAC. Miss this and you may end up self-paying in a transit city.

The seven common exclusions (detailed in next section). Full exclusion list only appears in the post-purchase policy document, but the seven common categories (dental, cosmetic, pre-existing, TCM, experimental therapy, fertility, maternity) are listed in the next section. Ask the broker how your specific tier handles each before buying.

Effective date and waiting periods. Between paying for the policy and the policy actually covering what you want there can be 5–30 days of underwriting plus 14 days to 24 months of category-specific waiting periods. If your trip is in 8 weeks, today's annual IPMI is unlikely to cover this trip's main treatment. This dimension has its own section below — it's tied directly to your travel dates.

Five major insurer fact sheets

The five insurers below account for 80%+ of broker-distributed cover for medical travelers and short-to-medium term foreigners (Pacific Prime State of Health Insurance Report 2025 plus iPMI Global Reports, cross-verified for 2026 status). We don't judge who's "best." Each insurer has strengths and weaknesses that depend on your specific scenario.

Cigna Global — the world's largest international medical insurer, 86M+ customers across 200+ countries. China is served via Cigna International Health channels with multiple JCI international hospitals and public-hospital international wings on direct billing. Tiers run Silver → Gold → Platinum. Cigna Silver opens at USD $365/mo for a 32yo American woman on the 2026 rate card; Premium with dental runs about USD $583/mo. Strengths: scale and global redundancy — you have a partner network in any major country. Weakness: scale slows the pace at which newly signed second-tier Chinese hospitals enter the network compared with APAC-focused smaller players.

Bupa Global — British heritage, plans split by geography into Network (restricted), Worldwide, and Worldwide-ex-USA. China direct billing is dense at Shanghai/Beijing/Shenzhen private international hospitals like the Jiahui/Raffles tier. Bupa is positioned mid-to-high-end; premiums sit in the upper half of these five. Strengths: British medical brand trust plus genuine global coverage on the Worldwide tier. Weakness: the Network restricted tier has fewer China options — match the tier to the target hospital before buying.

AXA Global Healthcare — five tiers: Foundation, Standard, Comprehensive, Prestige, Prestige Plus. Official disclosure: 80%+ of claims paid within 48 hours (complete docs assumed). AXA also runs a TPA (Third Party Administrator) arm in China, integrating deeply with local insurance structures. Strengths: tier granularity lets you match budget precisely; published claims-speed commitment. Weakness: five tiers confuse easily and Foundation covers less than many readers expect.

Allianz Care — has a dedicated "International Health Insurance for China" product line. The 2025 annual report disclosed 12% year-on-year growth in international medical enrollment. A 32yo American woman on a comprehensive plan typically pays under USD $500/mo. Strengths: continental European brand trust plus multilingual customer service (including Simplified Chinese). Weakness: tier naming doesn't normalize with Cigna or Bupa — cross-comparison requires explicit mapping.

Now Health International — APAC focus, headquartered in Hong Kong and Singapore. Three plans: SimpleCare, WorldCare, TopCare. Strengths: tighter optimization of hospital network coverage and customer service response across APAC; well-suited to readers seeking treatment across multiple Asian cities. Weakness: global scale is smaller than the previous four, so cross-continent claims are less convenient.

Figures reflect each insurer's 2026 published material; the "monthly start" column shows typical case from public quote tools — actual quotes depend on age, gender, health declaration, deductible.

Seven exclusions to verify before buying

Each insurer's exclusion list differs in detail, but the seven categories below are areas where international health insurance is generally stricter than buyers expect. Ask how your specific tier handles each before quoting — saves the awkward discovery during claims.

Dental. Standard international health plans usually don't include routine dental. Most insurers offer a dental rider at USD $30–$100/mo additional (by age, coverage limit, whether orthodontics is included). If your trip purpose is dental implants or orthodontics (dental is your main treatment), buying a standalone dental rider is usually cheaper than comprehensive health insurance plus dental.

Cosmetic / aesthetic. Pure cosmetic procedures (rhinoplasty, breast augmentation, liposuction, Botox, fillers) are excluded by almost all international health insurance — this is industry standard. There is no "cosmetic insurance" as a commercial product; individual broker-sold "cosmetic accident" policies cover only post-incident reconstruction, not elective cosmetic procedures.

Pre-existing conditions. Industry standard is a 2-year waiting period, but the definition of "pre-existing" varies: some insurers consider only "treated in the past 5 years," some look at "diagnosed in the past 10 years," some assess via individual underwriting. If you have any chronic condition under treatment (diabetes, hypertension, asthma, depression, arthritis, cancer follow-up), disclose proactively at quote — the consequence of non-disclosure is contract void plus all claims denied.

Traditional Chinese Medicine (TCM). Most international medical insurance does not cover TCM, acupuncture, or herbal medicine (rare exceptions exist as cultural-fit riders). If you plan TCM treatment, budget to self-pay.

Experimental therapies. CAR-T at the Hainan Boao Lecheng pilot zone, certain stem cell therapies, oncology protocols not internationally approved — these are typically classified as experimental or unproven and not covered.

Fertility treatment. Standard health plans do not include IVF or fertility treatments. Most insurers offer fertility riders, but with waiting periods (typically 12–24 months), lifetime coverage caps, and joint medical underwriting for both partners.

Maternity. Industry standard 12-month waiting period — meaning conception start must be later than the maternity benefit effective date + 12 months. If you're already pregnant or planning IVF in 8 weeks, today's new IPMI typically won't cover this pregnancy.

When the policy actually takes effect

International medical insurance isn't what you might think: from "I decide to buy" to "policy actually covers this surgery" there can be a 5-day to 24-month gap. Most buyers don't read this timeline carefully — they discover after purchase that the insurance doesn't apply to this trip.

First phase, underwriting 5–10 business days. Medical insurance is not bought off-the-shelf. You submit an application plus answer a medical questionnaire plus (possibly) supply medical exam reports. The insurer's underwriting team reviews. Simple cases (young, healthy, no chronic conditions) usually 3–5 business days; complex cases (multiple pre-existing, chronic medication, recent surgery) can stretch to 2–4 weeks. Short-term travel medical typically skips full medical underwriting — purchase is effective next day — but its pre-existing exclusions are accordingly strict.

Second phase, category-specific waiting periods. After underwriting passes and the policy is effective, different treatment categories have different waiting periods:

Specific days vary by insurer, tier, and whether a rider is added. At quote time you must ask the broker "what's the waiting period for [your planned treatment] on this tier" — don't assume.

Third thing, how to compress this timeline. If your itinerary is locked in and there's not much time before the policy must take effect, try these:

First, choose electronic-underwriting products. Some Cigna and Allianz products offer online questionnaire + instant underwriting (no human review), effective in 1–2 days, provided your health declaration has nothing requiring human review.

Second, ask the broker for pre-screening. Share your health situation with the broker first, let them internally screen before formal submission, avoiding the cascade where one insurer's rejection affects subsequent quotes. This is normal broker service, not a workaround.

Third, buy a "bridge policy." If your annual IPMI needs 4 weeks to take effect but you arrive in China in 2 weeks, buy a short-term travel medical insurance to cover the gap. Travel medical and annual IPMI don't conflict — incidents are handled per each contract.

Fourth, consider broader riders. Some insurers allow paying a surcharge to waive pre-existing waiting (from 2 years to 12–24 months), or choosing a higher tier that already includes specific treatment coverage (e.g. "standard fertility coverage" usually means a 12-month waiting period instead of 24). The price is a 15–40% premium increase.

Fourth thing, the 14–30 day free-look period. Most insurers offer a "free-look period" (also called "cooling-off period") of 14–30 days from purchase during which you can cancel for a full refund, provided no claims have been initiated. This is a buying-then-rethinking window — but single-use: once canceled, buying again (even from the same insurer) triggers fresh underwriting.

One-line summary: if your trip is within 8 weeks, annual IPMI likely won't cover this treatment. What you want is travel medical insurance plus self-pay plus home-country reimbursement, or consider delaying the trip until the pre-existing waiting period clears. This judgment must happen before you pay.

Five traps first-time buyers fall into

The five below are not "industry standards" or "fine print." They are what readers who already bought international medical insurance most often recall as "I wish I'd known." Understanding these puts your choice quality above 80% of similar buyers.

The health conditions you declare on the application become a permanent record. Multiple insurers' underwriting databases (such as MIB Group) are shared among major carriers. "Apply to insurer A first, if rejected go to B and say less" doesn't actually work — B receives your application, queries the database, sees A rejected, and aligns its own underwriting decision. The safest path is full disclosure from the start and asking the broker to compare which insurer is most likely to accept. Non-disclosure consequences include not just claim denial but contract void — meaning your paid premiums are not refunded.

The industry's waiting periods are pre-existing typically 2 years, maternity 12 months, fertility 12–24 months. If your trip is in 8 weeks, today's annual IPMI likely cannot cover the upcoming treatment, but you've already triggered underwriting and the permanent record is created. In this case you don't need annual IPMI (you can't use it); you need single-trip travel medical insurance plus self-pay plus home-country reimbursement. Most buyers miss this trip-date-versus-waiting-period mismatch before purchase, then discover the policy doesn't cover the main treatment afterward.

All five insurers' marketing pages claim "60+ partner hospitals in China" or similar numbers, but the specific list is only handed over after the policy is active. At quote stage, you can only use each insurer's hospital locator (incomplete coverage) or ask the broker to estimate (broker uses sales-oriented approximations). If you've already selected your target surgery hospital, the right move is: contact 1–2 brokers, tell them specifically "I'm going to hospital X for treatment Y," and have them cross-check in their internal system whether this hospital is in the current network of each candidate insurer. Brokers can look up this information but typically don't volunteer it.

Cigna Silver does not equal Bupa Silver does not equal AXA Foundation. Cigna's tier system is Silver → Gold → Platinum, Silver includes inpatient + some outpatient; Bupa's Silver is a mid-comprehensive plan including inpatient + outpatient + some dental; AXA's Foundation is the lowest of five tiers, inpatient only. Comparing by tier name ("Cigna Silver vs Bupa Silver") produces wrong conclusions — you must read each full coverage document (typically 30–60 page PDFs) for apples-to-apples comparison. A simplified mapping approach: decompose each insurer's tier into inpatient + outpatient + chronic condition management + dental + maternity, and see what each tier offers (yes/no plus limits) on those five axes.

International medical insurance, once bought, cannot be canceled mid-year for refund — pro-rata refunds are rare (some insurers offer full refund within the first 30 days only). Upgrading tier requires waiting for renewal + new underwriting, while your previously declared conditions are permanently locked. "Buy a cheap tier first to test, upgrade next year" doesn't work in practice — the renewal underwriting re-runs, and this year's medical usage affects new tier premium and acceptance. Best approach: choose the tier you actually need over the next 12 months from the start, leaning slightly above.

Once you've narrowed to 2–3 insurers

If you've completed the InsuranceFinder + read the five fact sheets, you should theoretically have narrowed 10 insurers to 2–3 candidates. The remaining work is converting "candidate" to "selected," which requires these steps.

Submit a quote request to 1–2 licensed brokers (Pacific Prime, Alea, Insubuy), specifying: (1) target stay length; (2) specific procedure or treatment name; (3) target hospitals (1–3 you've selected); (4) health declaration list (everything you're willing to upfront-disclose); (5) maximum monthly premium budget. Brokers typically return comparative quotations in 3–5 business days.

Brokers are sales-oriented — they earn commissions and tend to push products they have the deepest agreements with. This isn't bad (broker service genuinely saves you the hassle of running 5 insurers yourself), but you should have an independent second opinion. WellChina serves as that neutral second opinion: we have no broker affiliate agreements, so our recommendations rest on publicly available data plus China-side network verification.

One week before the final signing, verify "target hospital × candidate insurer current direct billing" once more — networks change. Bupa was contracted with Jiahui last month; it may have lapsed the grace period this week. This verification isn't proactively done by brokers, but you can request it. WellChina's Navigator tier bundles this into the service.

How we help

WellChina's role during your selection is to provide a neutral second opinion plus China-side network verification plus pre-trip pre-authorization timing coordination — so you're not stuck listening only to broker sales pitches or running across five insurers' quote tools yourself.

Specifically, we:

• Take your InsuranceFinder result + your target hospitals + current quote status, and deliver a personalized product-type recommendation PDF
• Verify your target hospitals' current direct-billing network status (3 candidate insurers × 1–3 hospitals you've selected, cross-checked against our hospital international medical department network)
• Provide a pre-trip pre-authorization timing schedule to align the 2–4 week pre-auth process with your surgery date
• Assist with post-discharge claims documentation and appeals path if needed

What we don't do: insurance brokerage (we have no broker license, cannot sign contracts on your behalf), underwriting decisions (you plus the broker decide), premium negotiation (broker's job), medical judgment, specific product recommendations ("you should buy Cigna" is the broker's role, not ours).

If you want a more hands-off experience:

• Starter (USD $29): 60-minute Zoom plus personalized product-type recommendation PDF (based on your InsuranceFinder result + target hospitals + current quote status). For travelers willing to execute themselves but wanting a professional second opinion before deciding.
• Navigator (USD $59): Everything in Starter plus target-hospital direct-billing network verification plus pre-trip pre-authorization timing schedule. For surgery + 14+ day trips.
• Concierge (USD $129+): Everything in Navigator plus post-discharge claims documentation assistance plus appeals path. For complex treatments, large claims, or patients who can't coordinate multiple channels themselves.

View service tiers → · Tell us your trip details →

---

WellChina takes no referral commissions from any insurer or broker mentioned in this guide. Recommendations are based on publicly available rate cards and industry reports as of 2026-05-11. Sources: Pacific Prime State of Health Insurance Report 2025, iPMI Global Reports, Cigna Global China, Bupa Global, AXA Global Healthcare China, Allianz Care China, Now Health International, internationalinsurance.com China comparison, expatden China insurance guide. Cross-verified 2026-05-11; next review 2026-08-11. Tier names, monthly premiums, direct-billing networks, waiting periods, and exclusions update quarterly; verify the latest with a broker or insurer before purchase. This article is informational only and does not constitute insurance or financial advice — consult a licensed insurance broker or financial advisor for specific purchase decisions. WellChina editorial team.